{"id":"https://openalex.org/W4393095461","doi":"https://doi.org/10.1158/1538-7445.am2024-1924","title":"Abstract 1924: RTK signaling and WT RAS activity as vulnerabilities in tumors with acquired resistance to GDP-state selective KRASG12C inhibitors in preclinical models","display_name":"Abstract 1924: RTK signaling and WT RAS activity as vulnerabilities in tumors with acquired resistance to GDP-state selective KRASG12C inhibitors in preclinical models","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393095461","doi":"https://doi.org/10.1158/1538-7445.am2024-1924"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-1924","doi":"https://doi.org/10.1158/1538-7445.am2024-1924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-1924","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035455861","display_name":"Hitendra Singh Solanki","orcid":"https://orcid.org/0009-0002-6306-731X","observed_orcids":["https://orcid.org/0009-0002-6306-731X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hitendra S. Solanki","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006337329","display_name":"Harshit Shah","orcid":"https://orcid.org/0000-0001-6138-6291","observed_orcids":["https://orcid.org/0000-0001-6138-6291"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harshit Shah","raw_affiliation_strings":["2Revolution Medicines, Inc. (RVMD), Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Revolution Medicines, Inc. (RVMD), Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025310869","display_name":"Denis J. Imbody","orcid":"https://orcid.org/0009-0004-9583-0388","observed_orcids":["https://orcid.org/0009-0004-9583-0388"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denis Imbody","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010829737","display_name":"Bina Desai","orcid":"https://orcid.org/0000-0003-0454-7583","observed_orcids":["https://orcid.org/0000-0003-0454-7583"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bina Desai","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087467089","display_name":"Paul A. Stewart","orcid":"https://orcid.org/0000-0003-0882-308X","observed_orcids":["https://orcid.org/0000-0003-0882-308X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Stewart","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076672524","display_name":"Bin Fang","orcid":"https://orcid.org/0000-0002-7636-1318","observed_orcids":["https://orcid.org/0000-0002-7636-1318","https://orcid.org/0000-0003-0506-2932"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Fang","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033834811","display_name":"Yaakov E. Stern","orcid":"https://orcid.org/0000-0002-2342-9497","observed_orcids":["https://orcid.org/0000-0002-2342-9497"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yaakov Stern","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087517890","display_name":"Lancia N. F. Darville","orcid":"https://orcid.org/0000-0002-9793-3741","observed_orcids":["https://orcid.org/0000-0002-9793-3741"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lancia N. Darville","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002876951","display_name":"John M. Koomen","orcid":"https://orcid.org/0000-0002-3818-1762","observed_orcids":["https://orcid.org/0000-0002-3818-1762"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Koomen","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009118439","display_name":"Andriy Marusyk","orcid":"https://orcid.org/0000-0002-0087-9575","observed_orcids":["https://orcid.org/0000-0002-0087-9575"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andriy Marusyk","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086386185","display_name":"Ethan Ahler","orcid":"https://orcid.org/0009-0001-0113-1956","observed_orcids":["https://orcid.org/0009-0001-0113-1956"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan Ahler","raw_affiliation_strings":["2Revolution Medicines, Inc. (RVMD), Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Revolution Medicines, Inc. (RVMD), Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078668389","display_name":"Ida Aronchik","orcid":"https://orcid.org/0009-0002-1590-8778","observed_orcids":["https://orcid.org/0009-0002-1590-8778"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ida Aronchik","raw_affiliation_strings":["2Revolution Medicines, Inc. (RVMD), Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Revolution Medicines, Inc. (RVMD), Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057362852","display_name":"Mallika Singh","orcid":"https://orcid.org/0009-0003-0234-1589","observed_orcids":["https://orcid.org/0009-0003-0234-1589"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mallika Singh","raw_affiliation_strings":["2Revolution Medicines, Inc. (RVMD), Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Revolution Medicines, Inc. (RVMD), Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064494204","display_name":"Eric B. Haura","orcid":"https://orcid.org/0000-0003-3114-1909","observed_orcids":["https://orcid.org/0000-0003-3114-1909"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric B. Haura","raw_affiliation_strings":["1Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"1924","last_page":"1924"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0940999984741211,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c-inhibitors","display_name":"KRAS G12C inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8669999837875366},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.7509999871253967},{"id":"https://openalex.org/keywords/rmc-7977","display_name":"RMC-7977","score":0.925000011920929},{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.7559999823570251},{"id":"https://openalex.org/keywords/adagrasib","display_name":"adagrasib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/met-phosphorylation","display_name":"MET phosphorylation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6389999985694885},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9200000166893005},{"id":"https://openalex.org/keywords/axl","display_name":"AXL","score":0.996999979019165},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5378192663192749},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5212057828903198},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.44530314207077026},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34897786378860474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3307972848415375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2542276978492737}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-1924","doi":"https://doi.org/10.1158/1538-7445.am2024-1924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-1924","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9074000120162964,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367602664","https://openalex.org/W3142010099","https://openalex.org/W4393100867","https://openalex.org/W4365511662","https://openalex.org/W4415701829","https://openalex.org/W7148630541","https://openalex.org/W4306404981","https://openalex.org/W4409690235","https://openalex.org/W4413421462","https://openalex.org/W7148815136"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"KRASG12C-GDP":[2,102,311,366],"Inhibitors":[3],"such":[4],"as":[5,223,333,410],"sotorasib":[6,86],"and":[7,44,76,87,94,101,108,126,134,147,167,190,204,244,297,319,406],"adagrasib":[8],"have":[9],"demonstrated":[10],"clinical":[11,55],"benefit":[12,27,48],"in":[13,74,80,150,179,200,208,263,273,310,320,338,346,412,422],"lung":[14],"cancer":[15],"patients":[16],"harboring":[17],"an":[18,173],"oncogenic":[19],"KRASG12C":[20,420],"mutation.":[21],"However,":[22],"the":[23,31,113,154,180,212,248,264,293,321,362,429],"durability":[24],"of":[25,33,37,47,64,120,145,160,214,219,226,284,323,428],"monotherapy":[26],"is":[28],"limited":[29],"by":[30,168,187],"development":[32],"resistance.":[34,368],"Hence,":[35],"identification":[36],"novel":[38],"treatment":[39,84],"approaches":[40],"to":[41,51,105,228,250,364,417],"overcome":[42],"resistance":[43,107,227,416],"extend":[45],"duration":[46],"becomes":[49],"necessary":[50],"address":[52,365],"this":[53],"unmet":[54],"need.":[56],"Experimental":[57],"Design:":[58],"We":[59,90,254],"generated":[60],"two":[61],"NSCLC":[62],"models":[63,313,424],"KRASG12C\u2212GDP":[65],"inhibitor":[66,295,367],"acquired":[67,415],"resistance,":[68],"named":[69],"sotorasib-R":[70,114,201,274],"LU65":[71,115,202,277],"(cell-line":[72],"derived,":[73],"vitro)":[75],"adagrasib-R":[77,155,181,209,265],"LUN156":[78,156,266],"(PDX-derived,":[79],"vivo)":[81],"following":[82],"extended":[83],"with":[85,292,302,329,340,358,414],"adagrasib,":[88],"respectively.":[89],"then":[91],"performed":[92],"transcriptomic":[93],"mass":[95,130],"spectrometry-based":[96,131],"phosphoproteomics":[97],"analyses":[98],"on":[99,217],"baseline":[100],"inhibitor-resistant":[103,312],"samples":[104],"determine":[106],"escape":[109],"mechanisms.":[110,253],"Results:":[111],"In":[112,153],"cells,":[116],"we":[117,142,231,281,288],"discovered":[118],"upregulation":[119],"various":[121],"RTKs":[122],"including":[123],"HER2,":[124],"HER3,":[125],"AXL":[127],"using":[128],"a":[129,139,224,235,290,334],"proteomics":[132],"approach":[133],"Immunoblot":[135],"analysis.":[136],"Simultaneously,":[137],"from":[138],"transcriptome":[140],"analysis,":[141],"observed":[143,163,282,298],"activation":[144,315],"RAS":[146,176,184,198,206,221,408],"PI3K/AKT":[148,285],"signaling":[149,207,222,241,405],"these":[151,252,330,347],"cells.":[152],"model,":[157,325],"increased":[158,196],"phosphorylation":[159],"MET":[161],"was":[162],"via":[164,242],"phospho-RTK":[165],"array":[166],"immunoblotting.":[169],"Transcriptomic":[170],"analysis":[171],"revealed":[172],"enrichment":[174],"for":[175,432],"pathway":[177],"dependency":[178,318],"tumor":[182,261,271,344],"models.":[183,348],"GTP-binding":[185],"assessed":[186],"RAF-RBD":[188],"pulldown":[189],"multiple":[191],"reactions":[192],"monitoring":[193],"mass-spectrometry":[194],"suggest":[195,308],"GTP-bound":[197],"isoforms":[199],"cells":[203],"active":[205],"LUN156.":[210],"Given":[211],"convergence":[213],"our":[215,303],"findings":[216],"re-activation/maintenance":[218],"wild-type":[220,245],"means":[225],"KRASG12C-GDP-state":[229],"inhibitors,":[230],"hypothesized":[232],"that":[233,309],"RMC-7977,":[234],"tri-complex":[236],"RASMULTI-GTP":[237,353],"inhibitor,":[238],"which":[239,258],"inhibits":[240],"mutant":[243],"RAS,":[246],"had":[247],"potential":[249,363],"counteract":[251],"tested":[255,289],"RMC-7977":[256,269,332],"monotherapy,":[257],"drove":[259,342],"complete":[260],"regressions":[262,345],"model.":[267],"Additionally,":[268],"attenuated":[270],"growth":[272],"cell":[275],"derived":[276],"xenograft":[278],"model":[279],"wherein":[280],"co-activation":[283],"signaling.":[286,327],"Thus,":[287],"combination":[291,339,357],"pan-PI3K":[294],"pictilisib":[296,341],"combinatorial":[299],"activity":[300,409],"consistent":[301],"findings.":[304],"Conclusions:":[305],"These":[306,349],"data":[307],"RTK":[314,404],"maintains":[316],"MAPK":[317],"case":[322],"one":[324],"PI3K":[326,359],"Consistent":[328],"mechanisms,":[331],"single":[335],"agent":[336],"or":[337,356],"significant":[343],"preclinical":[350,423],"results":[351],"indicate":[352],"inhibition":[354,360],"alone":[355],"has":[361],"Citation":[369],"Format:":[370],"Hitendra":[371],"S.":[372],"Solanki,":[373],"Harshit":[374],"Shah,":[375],"Denis":[376],"Imbody,":[377],"Bina":[378],"Desai,":[379],"Paul":[380],"A.":[381],"Stewart,":[382],"Bin":[383],"Fang,":[384],"Yaakov":[385],"Stern,":[386],"Lancia":[387],"N.":[388],"Darville,":[389],"John":[390],"M.":[391],"Koomen,":[392],"Andriy":[393],"Marusyk,":[394],"Ethan":[395],"Ahler,":[396],"Ida":[397],"Aronchik,":[398],"Mallika":[399],"Singh,":[400],"Eric":[401],"B.":[402],"Haura.":[403],"WT":[407],"vulnerabilities":[411],"tumors":[413],"GDP-state":[418],"selective":[419],"inhibitors":[421],"[abstract].":[425],"In:":[426],"Proceedings":[427],"American":[430],"Association":[431],"Cancer":[433,451],"Research":[434],"Annual":[435],"Meeting":[436],"2024;":[437],"Part":[438],"1":[439],"(Regular":[440],"Abstracts);":[441],"2024":[442],"Apr":[443],"5-10;":[444],"San":[445],"Diego,":[446],"CA.":[447],"Philadelphia":[448],"(PA):":[449],"AACR;":[450],"Res":[452],"2024;84(6_Suppl):Abstract":[453],"nr":[454],"1924.":[455]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2024-03-23T00:00:00"}